Leerink Partners Maintains Outperform on CVS Health, Lowers Price Target to $104
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice TargetHot
Leerink Partners analyst Michael Cherny maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $112 to $104.
Leerink Partners analyst Michael Cherny maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $112 to $104.